Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Bone healing critical for fusion success
Although developed originally in the 1990s, the drugs were rolled out slowly and initially only used for treatment of type 2 diabetes and other specific medical conditions
The GLP-1 drug class includes Ozempic and Mounjaro, which are prescribed to treat diabetes, and Wegovy made by Novo Nordisk, which has been approved to treat weight loss
It is important to note that regulatory bodies including the MHRA and EMA continue to monitor the safety profile of GLP-1 receptor agonists, including any potential psychiatric effects
The CagriSema metabolic preservation mechanism, specifically the maintenance of mitochondrial function in skeletal muscle during weight loss, could theoretically slow the rate of weight regain by preventing some of the metabolic adaptation that makes regain almost inevitable
